Alexion Pharmaceuticals
Seng H. Cheng has extensive experience in the pharmaceutical industry, holding prominent leadership positions focused on research and product development in rare diseases. Currently serving as the Senior Vice President of Research & Product Development at Alexion Pharmaceuticals, Cheng previously held significant roles at Pfizer as Senior Vice President & Chief Scientific Officer of the Rare Disease Research Unit, and at Sanofi as Global Head of Research for Rare Diseases. Additional experience includes positions at Genzyme as Group Vice President of Genetic Diseases Science and as a Staff Scientist at Integrated Genetics. Cheng holds a Ph.D. and a B.Sc. in Biochemistry from the University of London, completed between 1976 and 1983.
This person is not in any offices
Alexion Pharmaceuticals
45 followers
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer and autoimmune disorders.